This is a demo store. No orders will be fulfilled.
首页
400-620-6333
血液瘤CAR靶点
选项
-
Recombinant Human IL-3R alpha/CD123 Protein种属: 人(Human) Accession #: P26951-1表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Immobilized recombinant Human IL3 at 4 μg/mL (100 μL/well) can bind recombinant Human IL3RA, the EC50 of Human IL3RA is 5.3 μg/mL.
-
Recombinant Human CD38 Protein种属: 人(Human) Accession #: P28907表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Immobilized Human CD38 Protein at 1μg/mL (100 μL/well) can bind CD38 Rabbit pAb with a linear range of 0.244-3.2 ng/mL.
-
Recombinant Human CD99 Protein种属: 人(Human) Accession #: P14209-1表达系统: HEK293 蛋白标签: C-hFc & His 内毒素水平: <0.1 EU/μg生物活性: Immobilized CD99 Mouse mAb (Ab006798) at 2.0 μg/mL can bind biotinylated Recombinant Human CD99 Protein (rp144165) , the EC50 for this effect is 13.15 ng/mL.
-
Recombinant Human CD33 Protein种属: 人(Human) Accession #: P20138表达系统: HEK293 蛋白标签: C-hFc & His 内毒素水平: <0.1 EU/μg生物活性: 1、Measured by the ability of the immobilized protein to support the adhesion of human red blood cells. The ED50 for this effect is 1‑4 µg/mL. 2、Immobilized Recombinant Human CD33 Protein (rp143966) at 2.0 μg/mL can bind Gemtuzumab (anti-CD33) (Ab175859). The ED50 for this effect is 391.3 ng/mL.
-
Recombinant Human CD22 Protein种属: 人(Human) Accession #: P20273表达系统: HEK293 蛋白标签: C-Fc & His 内毒素水平: <0.1 EU/μg生物活性: Immobilized Recombinant Human CD22 Protein (rp143882) at 1 μg/mL can bind Recombinant CD22 Antibody (Ab094265) with a EC50 is 4.6 ng/mL.
-
Recombinant Human CD72 Protein种属: 人(Human) Accession #: P21854表达系统: HEK293 蛋白标签: C-hFc & His 内毒素水平: <0.1 EU/μg生物活性: Measured by the ability of the immobilized protein to induce IFN-gamma secretion in NK‑92 human natural killer lymphoma cells. The ED50 for this effect is 3-15 μg/mL.
-
Recombinant Human CD5 Protein种属: 人(Human) Accession #: P06127表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Recombinant Human CD5 can bind CD5 Antibody with a linear range of 0.800‑8.00 ng/mL.
-
Recombinant Human CD4 Protein种属: 人(Human) Accession #: P01730表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of HeLa human cervical epithelial carcinoma cells. The ED50 for this effect is 40.0 ng/mL. Measured by its binding ability in a functional ELISA. Immobilized Human CD4 protein (rp175911) at 1.0 μg/mL can bind Ibalizumab (anti-CD4) (Ab170728) with the EC50 of 52.66 ng/mL.
-
Recombinant Human ROR1 Protein种属: 人(Human) Accession #: Q01973表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human ROR1 Protein (rp176297) at 2.0 μg/mL can bind Zilovertamab (anti-ROR1) (Ab170644) , the EC50 is 16.07 ng/mL.
-
Recombinant Human PD-L1 Protein种属: 人(Human) Accession #: Q9NZQ7表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human PD-L1 Protein (rp169666) at 2.0 μg/mL can bind Sugemalimab (anti-PD-L1) (Ab175662) with the EC50 of 169.70 ng/mL. Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Avelumab (anti-PD-L1) (A412006) with the EC50 of 77.96 ng/mL. Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Envafolimab (anti-PD-L1) (Ab170617) with the EC50 of 339.40 ng/mL. Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Durvalumab (anti-PD-L1) (D412005) with the EC50 of 35.40 ng/mL.
-
Recombinant Human Siglec-3/CD33 Protein种属: 人(Human) Accession #: P20138表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: 1. Measured by the ability of the immobilized protein to support the adhesion of human red blood cells. The ED50 for this effect is < 6 µg/mL. 2. Immobilized Recombinant Human Siglec-3/CD33 Protein (rp169578) at 1.0 μg/mL can bind Vadastuximab (anti-CD33) (Ab182778) with the EC50 of 10.59 ng/mL. 3. Immobilized Recombinant Human Siglec-3/CD33 Protein (rp169578) at 1.0 μg/mL can bind Gemtuzumab (anti-CD33) (Ab175859) with the EC50 of 36.93 ng/mL.
-
Recombinant Human Siglec-2/CD22 Protein种属: 人(Human) Accession #: P20273表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind Inotuzumab (anti-CD22) (Ab176429) with the EC50 of 20.1 ng/mL. Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind bind Epratuzumab (anti-CD22) (Ab175532) with the EC50 of 207.0 ng/mL.
